AI healthcare - search results

There is little mainstream awareness of the condition that impacts one in ten women - currently, 30% of people with Polycystic ovary syndrome (PCOS) rely on online forums for information.

Professor Paramala Santosh, CEO of HealthTracker Ltd, co-developed the HealthTrackerTM platform – developed by clinicians, assisted by patients for patients, clinicians & researchers, more of which we learn about here.

We spoke with Dr Matthew Duchars, CEO of the UK’s first dedicated Vaccines Manufacturing and Innovation Centre (VMIC), about their work not only to provide an integral response to COVID-19, but as a centre of excellence advancing the vaccine sector on a global scale.

Here, Videx UK highlights how innovative hands-free door entry can help services return to normalcy post-COVID-19.

Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.

Sue Johnson Gregory, principal consultant, and Tim Powlson, senior business consultant at Entec Si, explain how to build a stronger, more joined up workforce in the face of future healthcare crises.

ONS data from January shows that only 49% of Black British adults would take the COVID vaccine - the UK Government acknowledges that others are wary about the intention of "some institutions and authorities".

Dr. Richie Kohman is the Lead of the Synthetic Biology Platform, a research division at Harvard University’s Wyss Institute which specializes in the reading and writing of biological systems for applications in healthcare, computing, and the environment He oversees all research in The Platform, encompassing projects related to in situ...

Lesley Youren, Hospital Segment Marketing Manager at Draeger Medical UK, talks about creating care-centred workplaces and improving staff satisfaction during a global pandemic.

We spoke with Tony Cecchin, Vice President and General Manager of Global Supplies at Zebra Technologies and President of Temptime Corporation, and Chris Caulfield, Vice President of Temptime Operations about their work supporting front-line workers and easing the shipment of medical products through the supply chain.

Several seasoned academic experts describe the move towards strengthening public health surveillance systems in Africa.

Andrew Mackie, VP Business Development tells us how Imcyse, a Belgian immunotherapy expert, seeks a curative approach to severe autoimmune diseases.

Mutlu Özcan, Prof. Dr Dr h.c., PhD from the University of Zürich, highlights Reconstructive Dentistry through new biomaterials and technologies, including the associated changes and challenges.

Dr Shireen Kassam MBBS, FRCPath, PhD, dipIBLM, Founder and Director of Plant-Based Health Professionals UK, explains a simple prescription for health as a remedy to chronic disease.

Dr Faye Riley, Senior Research Communications Officer at Diabetes UK, highlights how immunotherapy is raising hopes for the next big breakthrough in type 1 diabetes.

European Trade Union Institute’s Marian Schaapman explains how COVID-19 reveals the state of health and safety in the workplace.

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, explains the mind-body concept, from a philosophical question to clinical therapy.

The safety committee of the European Medicines Agency said the investigation did not prove that AstraZeneca vaccinations cause blood clots - describing the possibility as an "extremely small likelihood".

Dr Eugene Durenard, CEO of Hyperbolic Holdings GmbH discusses promising emerging technologies in the field of early detection and prevention of major chronic diseases.

Everard Munting, President of EUROSPINE, explains why sharing knowledge about spinal treatments on a global scale is the most effective way to develop best practice and enable early interventions.